Last update 21 Nov 2024

Ligufalimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
ligufalimab
+ [1]
Target
Mechanism
CD47 inhibitors(Cluster of differentiation 47 inhibitors)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous Cell Carcinoma of Head and NeckPhase 3
CN
16 Oct 2024
Metastatic Colorectal CarcinomaPhase 2
CN
27 Jul 2022
Advanced Triple-Negative Breast CarcinomaPhase 2
CN
23 Mar 2022
Metastatic Triple-Negative Breast CarcinomaPhase 2
CN
23 Mar 2022
Adenocarcinoma of EsophagusPhase 2
CN
30 Jan 2022
Rectal CancerPhase 2
CN
30 Jan 2022
stomach adenocarcinomaPhase 2
CN
30 Jan 2022
Advanced cancerPhase 2
CN
18 Jan 2022
High Risk Myelodysplastic SyndromePhase 2
HK
17 May 2021
Acute Myeloid LeukemiaPhase 1
CN
04 Jun 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
30
Ivonescimab monotherapy
(tnolubgwvh) = rdlrkphqzk xunixlkfyc (vdwkxoxaxe )
Positive
14 Sep 2024
(tnolubgwvh) = vaixhvplpo xunixlkfyc (vdwkxoxaxe )
Phase 2
Metastatic Colorectal Carcinoma
First line
KRAS | BRAF | MSS
40
FOLFOXIRI + Ivonescimab
(yqkuvhhdoe) = chvktmbomv zwukiqoogo (wsyevkpaub )
Positive
14 Sep 2024
FOLFOXIRI + Ivonescimab + Ligufalimab
(yqkuvhhdoe) = hxpkrgyazc zwukiqoogo (wsyevkpaub )
Phase 1
86
(uveyesmdpg) = arilevctsq bleclequnm (betvcquezv )
Positive
09 Dec 2023
Phase 2
16
cadonilimab+AK117+chemotherapy
(pspbcedccm) = sngqlsevvt rgbxasgtjp (trnupabivs )
Positive
26 May 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free